Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain
- PMID: 9300690
Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain
Abstract
Receptor oligomerization is important for ligand binding and signal transduction. CD44 is a transmembrane protein present on many cell types. One of the ligands for CD44 is hyaluronic acid (HA). HA binding activity of CD44 is linked to cellular activation in some cell types. Clustering of CD44 has been speculated to be important for binding of HA. However, the molecular mechanisms for converting CD44 from an inactive receptor to an active receptor are not known. Here we report that PMA stimulates the binding of CD44 to HA by inducing clustering of CD44 followed by covalent homodimerization of CD44 on the cell surface. Covalent dimerization involves a cysteine (Cys286) in the transmembrane domain of CD44 and is essential for binding of high levels of fluorescein-conjugated HA. Activation-induced clustering followed by disulfide bond-mediated dimerization of CD44 represents an additional signal transduction mechanism for regulating receptor-ligand interactions.
Similar articles
-
Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.Cell Immunol. 1998 Dec 15;190(2):132-40. doi: 10.1006/cimm.1998.1397. Cell Immunol. 1998. PMID: 9878114
-
Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.Cell Immunol. 1996 Nov 25;174(1):73-83. doi: 10.1006/cimm.1996.0295. Cell Immunol. 1996. PMID: 8929456
-
The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.Eur J Immunol. 2000 Jan;30(1):245-53. doi: 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.0.CO;2-X. Eur J Immunol. 2000. PMID: 10602047
-
Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.Proteins. 2000 May 1;39(2):103-11. Proteins. 2000. PMID: 10737932 Review.
-
Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.Arch Immunol Ther Exp (Warsz). 2004 Jan-Feb;52(1):13-26. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15053229 Review.
Cited by
-
Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.Drug Deliv Transl Res. 2013 Apr;3(2):121-42. doi: 10.1007/s13346-012-0075-1. Drug Deliv Transl Res. 2013. PMID: 25787981
-
CD44 in cancer progression: adhesion, migration and growth regulation.J Mol Histol. 2004 Mar;35(3):211-31. doi: 10.1023/b:hijo.0000032354.94213.69. J Mol Histol. 2004. PMID: 15339042 Review.
-
A low MW inhibitor of CD44 dimerization for the treatment of glioblastoma.Br J Pharmacol. 2020 Jul;177(13):3009-3023. doi: 10.1111/bph.15030. Epub 2020 Apr 5. Br J Pharmacol. 2020. PMID: 32080830 Free PMC article.
-
Characterization of the Wsc1 protein, a putative receptor in the stress response of Saccharomyces cerevisiae.Genetics. 1999 Aug;152(4):1487-99. doi: 10.1093/genetics/152.4.1487. Genetics. 1999. PMID: 10430578 Free PMC article.
-
Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization.J Biol Chem. 2015 Jul 10;290(28):17041-54. doi: 10.1074/jbc.M114.610204. Epub 2015 Apr 29. J Biol Chem. 2015. PMID: 25925953 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous